See more : HT Media Limited (HTMEDIA.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Oncoclínicas do Brasil Serviços Médicos S.A. (ONCO3.SA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Oncoclínicas do Brasil Serviços Médicos S.A., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Selçuk Ecza Deposu Ticaret ve Sanayi A.S. (SELEC.IS) Income Statement Analysis – Financial Results
- Siamese Asset Public Company Limited (SA.BK) Income Statement Analysis – Financial Results
- Valens Semiconductor Ltd. WT (VLN-WT) Income Statement Analysis – Financial Results
- Vamshi Rubber Limited (VAMSHIRU.BO) Income Statement Analysis – Financial Results
- Jacobs Engineering Group Inc. (J) Income Statement Analysis – Financial Results
Oncoclínicas do Brasil Serviços Médicos S.A. (ONCO3.SA)
About Oncoclínicas do Brasil Serviços Médicos S.A.
Oncoclínicas do Brasil Serviços Médicos S.A. provides medical services focused on clinical oncology and radiotherapy in Latin America. It offers services in the areas of chemotherapy, radiotherapy, hormone therapy, molecular target drugs, immunotherapy, bone marrow transplant, catheter heparinization, non-oncological infusions, laser therapy, myelogram - bone marrow biopsy, continuous care, and precision medicine. The company was founded in 2010 and is based in São Paulo, Brazil.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.49B | 4.09B | 2.70B | 2.04B | 1.69B | 1.05B | 791.84M | 594.81M | 457.97M | 359.45M | 269.14M |
| Cost of Revenue | 3.56B | 2.64B | 1.83B | 1.40B | 1.23B | 741.43M | 480.26M | 359.06M | 263.49M | 214.30M | 130.31M |
| Gross Profit | 1.93B | 1.45B | 868.79M | 635.68M | 460.53M | 309.41M | 311.58M | 235.75M | 194.48M | 145.16M | 138.83M |
| Gross Profit Ratio | 35.14% | 35.52% | 32.15% | 31.23% | 27.26% | 29.44% | 39.35% | 39.63% | 42.47% | 40.38% | 51.58% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 249.00K | 547.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.17B | 980.82M | 688.05M | 603.61M | 340.73M | 221.30M | 226.82M | 179.61M | 135.44M | 113.99M | 60.34M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.17B | 980.82M | 688.05M | 603.61M | 340.73M | 221.30M | 226.82M | 179.61M | 135.44M | 113.99M | 60.34M |
| Other Expenses | -1.51M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.17B | 981.01M | 691.58M | 616.06M | 338.77M | 237.68M | 243.93M | 196.52M | 149.48M | 117.90M | 70.15M |
| Cost & Expenses | 4.73B | 3.62B | 2.52B | 2.02B | 1.57B | 979.11M | 724.19M | 555.58M | 412.97M | 332.20M | 200.45M |
| Interest Income | 22.50M | 6.76M | 3.08M | 741.00K | 1.27M | 1.03M | 6.88M | 20.91M | 28.42M | 17.65M | 8.02M |
| Interest Expense | 559.79M | 396.47M | 154.36M | 72.07M | 41.61M | 26.61M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 257.37M | 175.15M | 126.97M | 106.81M | 64.10M | 17.93M | 11.61M | 13.49M | 8.39M | 5.56M | 1.09M |
| EBITDA | 1.17B | 730.36M | 337.08M | 126.43M | 196.11M | 95.98M | 54.43M | 55.68M | 49.51M | 23.92M | 80.16M |
| EBITDA Ratio | 21.28% | 17.32% | 12.60% | 5.94% | 11.01% | 9.36% | 6.87% | 9.36% | 10.81% | 6.66% | 29.79% |
| Operating Income | 758.02M | 470.57M | 177.22M | 19.62M | 121.76M | 82.74M | 42.83M | 42.19M | 41.12M | 18.37M | 79.08M |
| Operating Income Ratio | 13.81% | 11.51% | 6.56% | 0.96% | 7.21% | 7.87% | 5.41% | 7.09% | 8.98% | 5.11% | 29.38% |
| Total Other Income/Expenses | -455.50M | -349.03M | -114.88M | -85.32M | -41.39M | -28.97M | -7.39M | -21.63M | -24.54M | -21.57M | -8.47M |
| Income Before Tax | 302.52M | 121.54M | 62.34M | -57.12M | 80.37M | 53.77M | 60.77M | 18.33M | 16.58M | 9.60M | 60.66M |
| Income Before Tax Ratio | 5.51% | 2.97% | 2.31% | -2.81% | 4.76% | 5.12% | 7.67% | 3.08% | 3.62% | 2.67% | 22.54% |
| Income Tax Expense | -10.04M | 7.77M | 84.75M | 68.09M | 61.27M | 37.51M | 25.39M | 19.25M | 19.16M | 16.64M | 21.15M |
| Net Income | 223.62M | 46.26M | -46.90M | -159.62M | -20.42M | -17.08M | 3.15M | -25.36M | -24.77M | -22.17M | 20.50M |
| Net Income Ratio | 4.07% | 1.13% | -1.74% | -7.84% | -1.21% | -1.63% | 0.40% | -4.26% | -5.41% | -6.17% | 7.62% |
| EPS | 0.43 | 0.10 | -0.10 | -39.41 | -5.10 | -0.05 | 0.00 | -0.11 | -0.14 | -1.02 | 0.00 |
| EPS Diluted | 0.42 | 0.09 | -0.10 | -39.41 | -5.10 | -0.05 | 0.00 | -0.11 | -0.14 | -1.02 | 0.00 |
| Weighted Avg Shares Out | 523.65M | 479.83M | 474.78M | 4.05M | 4.00M | 359.09M | 31.45B | 225.04M | 171.47M | 21.70M | 0.00 |
| Weighted Avg Shares Out (Dil) | 535.52M | 531.70M | 474.78M | 4.05M | 4.00M | 359.09M | 31.45B | 225.04M | 171.47M | 21.70M | 0.00 |
Source: https://incomestatements.info
Category: Stock Reports